A Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of HRS-7535 in Adults With Type 2 Diabetic Kidney Disease
Latest Information Update: 20 May 2024
At a glance
- Drugs HRS-7535 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Shandong Suncadia Medicine
Most Recent Events
- 20 May 2024 New trial record